VBAC decision based on individual risk
For decades, the standard of practice for obstetricians was, "Once a cesarean, always a cesarean." That axiom was based on concern about how well the scar on the uterus that results from a cesarean would withstand labor.
The tide turned in the early 1980s based on several large studies and shifts in both popular opinion and medical practice. Women began to be encouraged to deliver vaginally. In fact, from 1989 to 1996, the rate of vaginal births after cesarean (VBACs) in the U.S. increased by 50 percent.
From 1989 to 1996, the rate of vaginal births after cesarean in the U.S. increased by 50%.
Almost all patients who had had a previous cesarean were encouraged to attempt a VBAC. In addition, induction of labor and the use of cervical ripening agents were also considered safe. But over the last two years, obstetricians have begun to question the broad-based commitment to VBACs, especially when it's necessary to ripen (soften) the cervix before inducing labor.
Why postaglandins are used
Obstetricians are frequently faced with situations where it is in the best interest of a particular patient to be delivered, but the woman's cervix, the opening to the uterus, is not favorable for a standard induction.
A class of compounds, called prostaglandins, have proven to be helpful in ripening the cervix so vaginal delivery is possible. The prostaglandins work by causing repetitive and, at times, strong uterine contractions, thus softening, thinning and dilating the cervix.
One particular prostaglandin, called misoprostol, is associated with most of the problems.
In general, a normal, unscarred uterus can handle the stimulation of the prostaglandins without significant risk. However, recent reviews of patients with previous C-section scars suggest there is a higher risk of uterine rupture than previously recognized.
One particular prostaglandin, called misoprostol, is associated with most of the problems. In fact, the American College of Obstetricians and Gynecologists has recommended against its use in patients who have had a previous C-section. The recent articles in the NEJM support that recommendation and suggest all prostaglandins when used for cervical ripening are associated with an increased risk of uterine tearing.
Patient selection is key
So should all patients who have had a C-section commit themselves to a repeat C-section? Not necessarily. There are alternative cervical ripening agents such as laminaria as well as the use of a Foley balloon.
Proper patient selection is key to safe vaginal deliveries. Physicians need to consider their patients' personal preference, general health and the reason for the first C-section. The type of uterine scar is also critical. Women with vertical scars are not considered safe candidates for a vaginal birth. Patients with a small pelvis, those who are carrying large babies and/or babies with a floating vertex (babies whose heads are not engaged in the birth position) and those with a very unfavorable cervix after their due date are not likely to be good candidates for a VBAC.
Properly selected patients
especially those who go into labor spontaneously, are likely to progress to a safe vaginal delivery.
Properly selected patients, however, especially those who go into labor spontaneously, are likely to progress to a safe vaginal delivery and avoid the risks associated with major surgical procedures such as C-sections.
Careful selection is key. Not all patients should attempt VBAC, but
many may be considered safe candidates. If the progress of labor slows
or stops, however, physicians need to re-evaluate the situation and
determine if an operative delivery is best.
Dr. Lynch is an attending gynecologist/obstetrician at Yale-New Haven Hospital and a clinical professor in obstetrics and gynecology at the Yale School of Medicine. He is a partner of the Greater New Haven Obstetrics/Gynecology Group with offices in New Haven, Orange and Hamden.